等待开盘 09-19 09:30:00 美东时间
0.000
0.00%
STRATA Skin Sciences announced the expansion of its patent portfolio to protect combination therapies using its XTRAC excimer laser with JAK inhibitors and biologic drugs, enhancing market exclusivity and growth opportunities. The company aims to include expanded CPT codes for all inflammatory and autoimmune skin conditions in the CMS physician fee schedule as early as January 1, 2026, significantly increasing patient reach and treatment economic...
09-02 12:05
导读:葛兰素史克正就收购生物技术公司IDRx进行谈判,后者专注于开发针对胃肠道间质瘤的药物,估值高达10亿美元。这笔潜在交易将增强葛兰素史克的肿瘤产品线。 据...
01-13 17:09
英国制药商葛兰素史克(GSK.US)周一表示,将斥资11.5亿美元收购美国生物技术公司IDRx。这笔交易包括10亿美元的预付款。此前有媒体援引知情人士消息报道称...
01-13 16:01
转自:中国医药报 近期,各大跨国药企陆续发布了2022年半年度业绩报告。辉瑞、罗氏、艾伯维、默沙东等10家企业表现亮眼。 ●辉瑞:上半年总营收超500亿美元...
2022-08-22 07:32
09:09 AM EDT, 06/17/2022 (MT Newswires) -- Sierra Oncology (SRRA) said Friday t...
2022-06-17 21:10
葛兰素史克周二表示,该公司将以33亿美元的价格收购美国生物制药公司Affinivax,以加强其疫苗管线。这是葛兰素史克两个月来的第二笔重大交易,它上个月斥资1...
2022-05-31 17:04
Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announced two abstracts have been accepted into the program for the
2022-05-27 05:11